# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Novo Nordisk confirms there is no anticipated shortage of Wegovy in Denmark, despite prior warnings from the Danish Medicines A...
Eli Lilly has settled with Totality Medispa over counterfeit Mounjaro and Zepbound sales. The spa will pay damages and cease us...
https://www.wsj.com/livecoverage/stock-market-today-dow-jones-05-14-2024/card/lilly-settles-with-spa-selling-mounjaro-zepbound-...
Argus Research analyst David Toung maintains Eli Lilly and Co (NYSE:LLY) with a Buy and raises the price target from $770 to...
Pfizer seeks to expands its reach with 'Pfizer for All,' offering direct-to-consumer medical services, including COVID ...
Google DeepMind reveals its AlphaFold 3, which specializes in molecular predictions for proteins, DNA, RNA, and drug molecules.